Catalyst Wire Dossier Catalyst Wire Dossier

ALN-TTRSC04

· Alnylam Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-TTRSC04, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects [Phase 1]

See pricing